Dipna Pharmachem informs about clarification sought on significant movement in price

With reference to Letter No - L/SURV/ONL/PV/AJ/2025-2026/3287 dated 13th January, 2026 received through email, with regard to significant movement in the price of the Company's scrip on Stock exchange, Dipna Pharmachem has informed that they have no price sensitive information / material information which can result / has resulted significant movement in price of the Company’s script. Further, Company has made all the disclosures under applicable Regulations of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, within the stipulated time period as per the regulations which may have a possible impact / fluctuation on the price of the Company's script. Further noted that currently there is no event / information / announcement that need to be reported by the Company to Stock Exchange. The volatility in the price of the Company’s script on the Stock Exchange is purely natural and market driven.

The above information is a part of company’s filings submitted to BSE.